Jon Adkins active positions
| Companies | Position | Start | End |
|---|---|---|---|
XenoTherapeutics, Inc.
 XenoTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services XenoTherapeutics, Inc. engages in xenotransplantation treatment services. It offers Xeno-Skin which is a humanitarian device for the treatment of severe burns and chronic wounds. The company was founded by Paul Holzer and Jon Adkins and is headquartered in Boston, MA. | Director/Board Member | - | - |
| Founder | - | - | |
| President | - | - | |
| Chief Operating Officer | - | - | |
| Corporate Officer/Principal | - | - | |
| Sales & Marketing | - | - | |
Alexis Bio LLC
 Alexis Bio LLC BiotechnologyHealth Technology Alexis Bio LLC operates as a clinical-stage biotechnology company. It develops a platform focused on immunogenomic reprogramming of live foreign cells from other species for the purpose of transplanting tissues and organs into human patients. The company was founded by Paul Holzer and Jon Adkins in 2019 and is headquartered in Enfield, NH. | Director/Board Member | - | - |
| Founder | - | - |
Career history of Jon Adkins
Statistics
International
| United States | 3 |
Operational
| Director/Board Member | 2 |
| Founder | 2 |
| Chief Operating Officer | 1 |
Sectoral
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
XenoTherapeutics, Inc.
XenoTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services XenoTherapeutics, Inc. engages in xenotransplantation treatment services. It offers Xeno-Skin which is a humanitarian device for the treatment of severe burns and chronic wounds. The company was founded by Paul Holzer and Jon Adkins and is headquartered in Boston, MA. | Commercial Services |
Alexis Bio LLC
Alexis Bio LLC BiotechnologyHealth Technology Alexis Bio LLC operates as a clinical-stage biotechnology company. It develops a platform focused on immunogenomic reprogramming of live foreign cells from other species for the purpose of transplanting tissues and organs into human patients. The company was founded by Paul Holzer and Jon Adkins in 2019 and is headquartered in Enfield, NH. | Health Technology |
- Stock Market
- Insiders
- Jon Adkins
- Experience
